Intellipharmaceutics International Inc.
featured news
August 31, 2023
Cases
Another Canadian Cannabis company offers millions to resolve shareholder class action
(August 30, 2023). We are pleased to announce that the Ontario Superior Court of Justice (the “Court”) has scheduled a hearing to be held on November 14, 2023 the “Settlement Approval Hearing”) to approve a settlement among in Daniel Relvas v. Auxly Cannabis Group Inc., bearing Court File No. CV-19-00617136-00CP (the “Action”). Background The Action was […]
August 1, 2023
News
Berger Montague (Canada) PC adds Senior Associate Litigator
(August 1, 2023). Vincent DeMarco has joined Berger Montague (Canada) PC as a Senior Associate. Prior to joining the firm, Vincent practiced commercial litigation, including disputes relating to securities, contracts, corporate governance, bankruptcy, civil fraud, defamation, real estate, and obtaining injunctive relief. Vincent previously worked in the Toronto office of […]
June 24, 2023
News
Another Cannabis Company smokes its investors: Restatement, Stock Drop, while Insiders get rich
(June 23, 2023) On May 10, 2023, Canopy Growth Corp. announced that it had discovered material errors with its accounting practices as it related to its BioSteel Sports Nutrition Inc. (“BioSteel”): “material misstatements… sales in the BioSteel business unit… timing of revenue recognition… material weaknesses in internal controls over financial […]
May 30, 2023
Cases
Court of Appeals provides Investors are provided guidance as to how to recover money from dishonest companies
(May 24, 2023) The Ontario Court of Appeal (Simmons, Benotto and Favreau JJ.A.) released a long waited decision in Markowich v. Lundin Mining Corporation concerning the interpretation and application of a “material change” within the Securities Act and when a responsible issuer must make disclosure of the material change. This […]
April 20, 2023
News
Another Investment Gone Up in Smoke: Where are the Regulators?
(April 13, 2023). The Ontario Superior Court of Justice, Honourable E.M. Morgan, issued a direction that he will refrain from further motion practice so the representative investors in the 4 Canadian class actions can prepare to resolve all the claims on behalf of all investors that purchased Wayland Group Corp.’s securities in […]
schedule a free consultation
$200M+
In Canadian Settlements
Top 50
ISS SCAS Top 50 (2017-2021)
10+
Years Representing Canadian Investors
12+
Canadian Court Decisions Advancing Investors’ Rights
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
